The Impact of Dystrophin Gene Mutation Sites on Electroretinogram Abnormalities in Mouse Models of Duchenne Muscular Dystrophy - Top-Institutions - MDSpire

The Impact of Dystrophin Gene Mutation Sites on Electroretinogram Abnormalities in Mouse Models of Duchenne Muscular Dystrophy

  • By

  • André Maurício Passos Liber

  • Mirella Barboni

  • Yoshitsugu Aoki

  • Jan Kremers

  • Cyrille Vaillend

  • April 25, 2026

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    University of California, Los Angeles (UCLA) - Center for Duchenne Muscular Dystrophy
    University of California, Los Angeles (UCLA) - Center for Duchenne Muscular Dystrophy

    Los Angeles, CA

    Key Differentiators

    • Neurology
    • Genetics
    • Ophthalmology
    • Muscular Dystrophy Research

  • #2

    Johns Hopkins University School of Medicine - Neuromuscular and Retinal Research Programs
    Johns Hopkins University School of Medicine - Neuromuscular and Retinal Research Programs

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Genetics
    • Ophthalmology

  • #3

    Massachusetts General Hospital (MGH) - Neurology and Ophthalmology Departments
    Massachusetts General Hospital (MGH) - Neurology and Ophthalmology Departments

    Boston, MA

    Key Differentiators

    • Neurology
    • Ophthalmology
    • Genetics

  • #4

    University of Oxford - Nuffield Department of Clinical Neurosciences
    University of Oxford - Nuffield Department of Clinical Neurosciences

    Oxford, UK

    Key Differentiators

    • Neurology
    • Genetics
    • Neuroscience

Original Source(s)

The Impact of Dystrophin Gene Mutation Sites on Electroretinogram Abnormalities in Mouse Models of Duchenne Muscular Dystrophy

  • by André Maurício Passos Liber, Mirella Barboni, Yoshitsugu Aoki, Jan Kremers, Cyrille Vaillend

  • April 25, 2026

Related Content

Robust and reproducible population receptive field mapping in patients with retinal pathologies

Real-World Findings Reinforce Encelto’s Role in MacTel Treatment

Roger A. Goldberg, MD, MBA, shared early postapproval experience with Encelto, including an evolving surgical technique, at Clinical Trials at the Summit.

PANoptosis in diabetic retinopathy: immunological insights into mechanisms and translational therapies